Judith Schilling

Inhibition of the MID1 protein complex: a novel approach targeting APP protein synthesis

Frank Matthes, Moritz M. Hettich, Judith Schilling et al. · Cell Death Discovery · 2018 · 59 citations · Full text

Life Sciences, Neuroscience, Pharmacology +13

The induction of human myeloid derived suppressor cells through hepatic stellate cells is dose-dependently inhibited by the tyrosine kinase inhibitors nilotinib, dasatinib and sorafenib, but not sunitinib

Annkristin Heine, Judith Schilling, Barbara T. Grünwald et al. · Cancer Immunology Immunotherapy · 2016 · 42 citations · Full text

Medicine, Oncology, Pharmacology +15

Reducing Mutant Huntingtin Protein Expression in Living Cells by a Newly Identified RNA CAG Binder

Frank Matthes, Serena Massari, Anna Bochicchio et al. · ACS Chemical Neuroscience · 2018 · 36 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial

Thomas Zeyen, Anna‐Laura Potthoff, Robert Németh et al. · Trials · 2022 · 32 citations · Full text

Medicine, Oncology, Pharmacology +15

Regulation of mRNA Translation by MID1: A Common Mechanism of Expanded CAG Repeat RNAs

Nadine Griesche, Judith Schilling, Stephanie Weber et al. · Frontiers in Cellular Neuroscience · 2016 · 30 citations · Full text

Life Sciences, Genetics, Molecular Biology +17